Whilst discounted playing cards can help relieve the stress of substantial drug prices in the temporary, they do not handle the systemic challenges driving up prescription selling prices from the U.S. Broader policy adjustments could tackle the basis leads to of soaring drug costs, for example lack of transparency in pricing and the role of interme